text.skipToContent text.skipToNavigation
  1. Home
  2. Product Categories
  3. Pharmaceutical Ingredients
  4. Standards for Pharma
  5. Bendamustine hydrochloride monohydrate
  6. DCE | (4-{5-[2-chlorethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid))

DCE | (4-{5-[2-chlorethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid))

Internal Heraeus Name: DCE | (4-{5-[2-chlorethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid))

Product Details

  • ID
    5012226
  • Product Type
    Standard  
  • Packaging/Sample size
    0,1  g
  • Packaging Type
    Glass vials  

Danger

Pricing

Price excl. VAT, incl. shipping and packaging

Quantity/UoM Base

Order Quantity
Increasing order volume can lead to reduced price per unit of measure.
Request for Quote

Additional Information

Classification of the Substance or Mixture

Acute toxicity Category 3 | H301: Toxic if swallowed.
Germ cell mutagenicity Category 1B | H340: May cause genetic defects.
Carcinogenicity Category 1A | H350: May cause cancer.
Reproductive toxicity Category 1B | H360: May damage fertility or the unborn child.
Specific target organ toxicity - repeated exposure Category 2 | H373: May cause damage to organs through prolonged or repeated exposure.

Description

Chemical formula C14H18CIN3O2
Chemical name (4-{5-[2-chlorethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid))

Identification

Heraeus Ident-No. 5012226
CAS - Number 1219709-86-0
Request product modification

Documents

Request a document

Benefits and Applications

Classification of the Substance or Mixture (outside EU)

Purchases in this shop may only be made by businesses, universities and research institutes, not by consumers. | Pay by invoice.